Related references
Note: Only part of the references are listed.Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma (vol 55, pg 1041, 2011)
Wei-Tien Tai et al.
JOURNAL OF HEPATOLOGY (2017)
Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity
Kuen-Feng Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis
Po-Jen Chen et al.
HEPATOLOGY (2012)
Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma
Satoshi Shimizu et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Chemoembolization for intermediate HCC: Is there proof of survival benefit?
Alejandro Forner et al.
JOURNAL OF HEPATOLOGY (2012)
Dovitinib Induces Apoptosis and Overcomes Sorafenib Resistance in Hepatocellular Carcinoma through SHP-1-Mediated Inhibition of STAT3
Wei-Tien Tai et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Protecting a healthy circulation
Kim Baumann
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Obatoclax and Lapatinib Interact to Induce Toxic Autophagy through NOXA
Yong Tang et al.
MOLECULAR PHARMACOLOGY (2012)
Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis
Ying-Hong Shi et al.
AUTOPHAGY (2011)
The Beclin 1 network regulates autophagy and apoptosis
R. Kang et al.
CELL DEATH AND DIFFERENTIATION (2011)
MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated manner
Marc Germain et al.
EMBO JOURNAL (2011)
Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf
Kuen-Feng Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
p62 targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding
Eisuke Itakura et al.
JOURNAL OF CELL BIOLOGY (2011)
Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma
Wei-Tien Tai et al.
JOURNAL OF HEPATOLOGY (2011)
STAT3 transcriptional factor activated by reactive oxygen species induces IL6 in starvation-induced autophagy of cancer cells
Sarah Yoon et al.
AUTOPHAGY (2010)
Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
Kuen-Feng Chen et al.
CLINICAL CANCER RESEARCH (2010)
Crosstalk between apoptosis and autophagy within the Beclin 1 interactome
Maria Chiara Maiuri et al.
EMBO JOURNAL (2010)
Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives
Ying-Chun Shen et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Gender Disparity of Hepatocellular Carcinoma: The Roles of Sex Hormones
Shiou-Hwei Yeh et al.
ONCOLOGY (2010)
Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-X-L
Einat Zalckvar et al.
AUTOPHAGY (2009)
Sorafenib Inhibits Signal Transducer and Activator of Transcription-3 Signaling in Cholangiocarcinoma Cells by Activating the Phosphatase Shatterproof 2
Boris R. A. Blechacz et al.
HEPATOLOGY (2009)
Identification of Androgen Response Elements in the Enhancer I of Hepatitis B Virus: A Mechanism for Sex Disparity in Chronic Hepatitis B
Sheng-Han Wang et al.
HEPATOLOGY (2009)
Bortezomib Overcomes Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
Kuen-Feng Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
An insight into the mechanistic role of Beclin 1 and its inhibition by prosurvival Bcl-2 family proteins
Bonsu Ku et al.
AUTOPHAGY (2008)
Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells
Kuen-Feng Chen et al.
CANCER RESEARCH (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Roles of mTOR and STAT3 in autophagy induced by telomere 3′ overhang-specific DNA oligonucleotides
Tomohisa Yokoyama et al.
AUTOPHAGY (2007)
BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-XL
Maria Chiara Maiuri et al.
AUTOPHAGY (2007)
Functional and physical interaction between Bcl-XL and a BH3-like domain in Beclin-1
M. Chiara Maiuri et al.
EMBO JOURNAL (2007)
Self-eating and self-killing: crosstalk between autophagy and apoptosis
M. Chiara Maiuri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
Another way to die: autophagic programmed cell death
Y Tsujimoto et al.
CELL DEATH AND DIFFERENTIATION (2005)
Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy
S Pattingre et al.
CELL (2005)
Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia
JH Kao et al.
LIVER INTERNATIONAL (2005)
STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes
Q Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
